These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 29028221)
1. Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review. Verma V; Simone CB; Mishra MV J Natl Cancer Inst; 2018 Apr; 110(4):. PubMed ID: 29028221 [TBL] [Abstract][Full Text] [Related]
2. A systematic review of the cost and cost-effectiveness studies of proton radiotherapy. Verma V; Mishra MV; Mehta MP Cancer; 2016 May; 122(10):1483-501. PubMed ID: 26828647 [TBL] [Abstract][Full Text] [Related]
3. Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials. Mishra MV; Aggarwal S; Bentzen SM; Knight N; Mehta MP; Regine WF Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):228-235. PubMed ID: 28068231 [TBL] [Abstract][Full Text] [Related]
4. Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation. Verma V; Rwigema JM; Malyapa RS; Regine WF; Simone CB Radiother Oncol; 2017 Oct; 125(1):21-30. PubMed ID: 28941560 [TBL] [Abstract][Full Text] [Related]
5. A Systematic Review of the Economic Burden of Proton Therapy in Head and Neck Cancer. Bharathi R P; Ms A; Kamath A Asian Pac J Cancer Prev; 2023 Nov; 24(11):3643-3653. PubMed ID: 38019221 [TBL] [Abstract][Full Text] [Related]
6. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis. Dutz A; Agolli L; Baumann M; Troost EGC; Krause M; Hölscher T; Löck S Acta Oncol; 2019 Jun; 58(6):916-925. PubMed ID: 30882264 [No Abstract] [Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
8. Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities. Prasanna PG; Rawojc K; Guha C; Buchsbaum JC; Miszczyk JU; Coleman CN Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1325-1340. PubMed ID: 33640423 [TBL] [Abstract][Full Text] [Related]
9. Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancer. Bai M; Gergelis KR; Sir M; Whitaker TJ; Routman DM; Stish BJ; Davis BJ; Pisansky TM; Choo R Cancer Med; 2020 Nov; 9(21):7925-7934. PubMed ID: 32931662 [TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes and Toxicity of Proton Radiotherapy for Breast Cancer. Verma V; Shah C; Mehta MP Clin Breast Cancer; 2016 Jun; 16(3):145-54. PubMed ID: 26995159 [TBL] [Abstract][Full Text] [Related]
11. [Proton beam therapy]. Ogino T Gan To Kagaku Ryoho; 2006 Apr; 33(4):450-4. PubMed ID: 16612152 [TBL] [Abstract][Full Text] [Related]
12. [Heavy charged particle radiotherapy--proton beam]. Ogino T Gan To Kagaku Ryoho; 2003 Dec; 30(13):2030-5. PubMed ID: 14712761 [TBL] [Abstract][Full Text] [Related]
13. Proton beam therapy for skull base chordomas: a systematic review of tumor control rates and survival rates. Pahwa B; Medani K; Lu VM; Elarjani T Neurosurg Rev; 2022 Dec; 45(6):3551-3563. PubMed ID: 36181614 [TBL] [Abstract][Full Text] [Related]
14. Prospective Analysis of Radiation-Induced Contrast Enhancement and Health-Related Quality of Life After Proton Therapy for Central Nervous System and Skull Base Tumors. Lütgendorf-Caucig C; Pelak M; Hug E; Flechl B; Surböck B; Marosi C; Mock U; Zach L; Mardor Y; Furman O; Hentschel H; Gora J; Fossati P; Stock M; Graichen U; Klee S; Georg P Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1206-1216. PubMed ID: 38244874 [TBL] [Abstract][Full Text] [Related]
15. Commentary on "Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer." Gray PJ, Paly JJ, Yeap BY, Sanda MG, Sandler HM, Michalski JM, Talcott JA, Coen JJ, Hamstra DA, Shipley WU, Hahn SM, Zietman AL, Bekelman JE, Efstathiou JA. Harvard Radiation Oncology Program, Boston, MA.: Cancer 2013;119(9):1729-35. doi: 10.1002/cncr.27956. [Epub 2013 Feb 22]. Gottschalk A Urol Oncol; 2014 Apr; 32(3):373-4. PubMed ID: 24679463 [TBL] [Abstract][Full Text] [Related]
16. Proton beam therapy in rectal cancer: A systematic review and meta-analysis. Fok M; Toh S; Easow J; Fowler H; Clifford R; Parsons J; Vimalachandran D Surg Oncol; 2021 Sep; 38():101638. PubMed ID: 34340196 [TBL] [Abstract][Full Text] [Related]